These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26880216)
1. Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease. Kerroch M; Alfieri C; Dorison A; Boffa JJ; Chatziantoniou C; Dussaule JC Sci Rep; 2016 Feb; 6():21262. PubMed ID: 26880216 [TBL] [Abstract][Full Text] [Related]
2. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease. Dorison A; Dussaule JC; Chatziantoniou C Nephron; 2017; 137(3):212-220. PubMed ID: 28743124 [TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Guerrot D; Kerroch M; Placier S; Vandermeersch S; Trivin C; Mael-Ainin M; Chatziantoniou C; Dussaule JC Am J Pathol; 2011 Jul; 179(1):83-91. PubMed ID: 21640971 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model. Bansod S; Saifi MA; Godugu C Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346 [TBL] [Abstract][Full Text] [Related]
9. DDR1: A major player in renal diseases. Dorison A; Chantziantoniou C Cell Adh Migr; 2018; 12(4):299-304. PubMed ID: 29455614 [TBL] [Abstract][Full Text] [Related]
10. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3. Borza CM; Bolas G; Bock F; Zhang X; Akabogu FC; Zhang MZ; de Caestecker M; Yang M; Yang H; Lee E; Gewin L; Fogo AB; McDonald WH; Zent R; Pozzi A JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34941574 [TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Takai K; Drain AP; Lawson DA; Littlepage LE; Karpuj M; Kessenbrock K; Le A; Inoue K; Weaver VM; Werb Z Genes Dev; 2018 Feb; 32(3-4):244-257. PubMed ID: 29483153 [TBL] [Abstract][Full Text] [Related]
12. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome. Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991 [TBL] [Abstract][Full Text] [Related]
13. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome. Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219 [TBL] [Abstract][Full Text] [Related]
14. Novel Targets for Therapy of Renal Fibrosis. Prakoura N; Hadchouel J; Chatziantoniou C J Histochem Cytochem; 2019 Sep; 67(9):701-715. PubMed ID: 31116064 [TBL] [Abstract][Full Text] [Related]
15. Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease. Soomro I; Hong A; Li Z; Duncan JS; Skolnik EY PLoS One; 2019; 14(7):e0211670. PubMed ID: 31260458 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression. Barisione G; Fabbi M; Cutrona G; De Cecco L; Zupo S; Leitinger B; Gentile M; Manzoni M; Neri A; Morabito F; Ferrarini M; Ferrini S Blood Cancer J; 2017 Jan; 6(1):e513. PubMed ID: 28060374 [No Abstract] [Full Text] [Related]